🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Orbimed Advisors - Q2 2026 13F Filings

OR

Orbimed Advisors LLC

CIK: 0001055951
Address: New York New York 601 Lexington Avenue 54Th Floor
$5.37 B
Portfolio Value
128
Assets Held
Reporting Period: Q2 2026
Filing Status:
Active
Last Updated: 11/16/2026

Portfolio Summary (Q2 2026)

View Full Portfolio Analysis

Top Sells

Q2 2026

Asset Allocation

Stocks/ETFs
+14.78%
$5.24 B 97.58%
Options
-74.48%
$117.38 M 2.19%
Debt
+930.68%
$12.57 M 0.23%
Other
$0 0.00%

Sector Allocation (Stocks)

Orbimed Advisors Q2 2026 Filing Summary

Orbimed Advisors LLC filed its 13F report for Q2 2026 on August 14, 2026. The portfolio totaled 5.37 B reflecting a +6.83% change from the prior quarter, spanning 128 assets. The top 10 holdings comprised 43.4% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 31 new positions and 20 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Orbimed Advisors’s Q2 2026 Filing

Orbimed Advisors submitted their Form 13F-HR for the Q2 2026 period on 08/14/2026. This was the only submission for the quarter.

In the Q2 2026 filing, Orbimed Advisors reported a managed portfolio value of 5.4 B, consisting of 129 individual positions.

This page displays the raw filing documents. To see which stocks Orbimed Advisors bought or sold during Q2 2026, please visit Orbimed Advisors's Portfolio Analysis page.